RPTX — Repare Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Repare Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	334	342	344	224	153
Net Total Receivables	6.16	3.23	4.32	15.3	12.3
Prepaid Expenses
Total Current Assets	347	351	354	244	171
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.62	13.1	9.6	7.54	4.22
Long Term Notes Receivable
Other Long Term Assets
Total Assets	357	369	364	254	177
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11	35.1	78.6	39.1	25.3
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	70.3	80.3	84.6	41.8	25.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	287	288	280	212	151
Total Liabilities & Shareholders' Equity	357	369	364	254	177
Total Common Shares Outstanding